Screening History among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?

Journal of Women's Health

Volumn 25, Issue 8, 2016, Pages 826-831

  Nitschmann, Caroline ^a   May, Taymaa ^b   Mirkovic, Jelena ^c   Feldman, Sarah ^c  

^a MAYO CLINIC   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; ORAL CONTRACEPTION; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; SMOKING; TUMOR INVASION; UTERINE CERVIX CANCER; ADENOCARCINOMA; AGED; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STANDARDS; UNIVERSITY HOSPITAL; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

ACADEMIC MEDICAL CENTERS; ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; PAPANICOLAOU TEST; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84981316074     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2015.5394     Document Type: Article

References (29)

1. Howlader N, Noone AM, Krapcho M, et al., eds. SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer Institute, 2012. Available at: http://seer.cancer.gov/csr/1975-2009-pops09 (accessed July 27, 2012)
2. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000;88:2283-2289
3. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. J Natl Cancer Inst 2005;97:675-683
4. Freeman HP, Wingrove BK. Excess cervical cancer mortality: A marker for low access to health care in poor communities. NIH Pub. No. 05-5282. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities, 2005. Available at: http://crchd.cancer.gov/attachments/ excess-cervcanmort.pdf (accessed August 2, 2012)
5. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: Systematic review and metaanalysis. Prev Med 2007;45:93-106
6. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. National Center for Health Statistics. Vital Health Stat 10 2012;(252):1-207
7. Lee KR, Minter LJ, Granter SR. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases. Am J Clin Pathol 1997;107:30-35
8. van Hanegem N, Barroilhet LM, Nucci MR, Bernstein M, Feldman S. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix. Gynecol Oncol 2012;124:72-77
9. Schneider A, Erdemoglu E, Chiantera V, et al. Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer. Int J Gynecol Cancer 2012;22:659-666
10. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012;16:175-204
11. Cervical Cancer Screening. U.S. Preventive Services Task Force, 2012. Available at: www.uspreventiveservicestaskforce .org/Page/Document/UpdateSummaryFinal/cervical-cancerscreening Accessed May 15, 2015
12. Massad, LS, Einstein MH, Huh WK, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;14:s1-s27
13. American College of Obstetricians and Gynecologists. Practice Bulletin No. 140: Management of abnormal cervical cancer screening tests results and cervical cancer precursors. Obstet Gynecol 2013;122:1338-1367
14. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER Stat Database: Research Data, Nov 2011 Sub (2004-2008)
15. Wang SS, ShermanME, HildesheimA, Lacey JV, Jr.,Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among whitewomen and black women in the United States for 1976-2000. Cancer 2004;100:1035
16. Lacey JV, Jr., Swanson CA, Brinton LA, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003;98:814
17. Madeleine MM, Daling JR, Schwartz SM, et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001;10:171
18. Hacker NF, Friedlander ML. Cervical cancer. In: Berek and Hacker's Gynecologic Oncology, 5th Edition. Philadelphia, PA; Lippincott Williams &Wilkins;2010;341-387
19. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study. Gynecol Oncol 2000;78:97-105
20. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005;113: 1005-1009
21. Boon ME, Baak JP, Kurver PJ, Overdiep SH, Verdonk GW. Adenocarcinoma in situ of the cervix: An underdiagnosed lesion. Cancer 1981;48:768-773
22. Krane JF, Granter SR, Trask CE, Hogan CL, Lee KR. Papanicolaou smear sensitivity for the detection of adenocarcinomaof the cervix:Astudy of 49 cases. Cancer 2001;93:8-15
23. Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases. Gynecol Oncol 2000;79:207
24. Plaxe SC, Saltztein SL. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol 1999;75:55
25. Barakat R, Berchuck A, Markman M, Randall M. Cervical cancer. Principles and practice of gynecologic oncology, 6th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams &Wilkins, 2013
26. Lee KR, Flynn CE. Early invasive adenocarcinoma of the cervix. Cancer 2000;89:1048
27. Barroilhet L, Van Hanegem L, Bernstein M, Feldman S. Potential effects of updated pap test screening guidelines and adenocarcinoma in situ of the cervix. Obstet Gynecol 2013;121:759-764
28. Cervical Cancer Incidence Rates by State. CDC, 2012. Available at: www.cdc.gov/cancer/cervical/statistics/state .htm Accessed May 15, 2015
29. Shalowitz D, Vinograd A, Giuntoli R. Geographic access to gynecologic cancer care in the United States. Gynecol Oncol 2015;138:115-120